Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998–2006: factors associated with improved survival outcome

This publication has 23 references indexed in Scilit:

• Multiple myeloma
  Blood, 2008
• Nonmyeloablative Unrelated Donor Hematopoietic Cell Transplantation to Treat Patients with Poor-Risk, Relapsed, or Refractory Multiple Myeloma
  Transplantation and Cellular Therapy, 2007
• Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning
  Blood, 2006
• Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT
  Blood, 2005
• Outcome of unrelated transplants in patients with multiple myeloma
  Bone Marrow Transplantation, 2005
• The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma
  Blood, 2004
• Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation
  Bone Marrow Transplantation, 2004
• Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning
  Experimental Hematology, 2003
• Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma
  Bone Marrow Transplantation, 2001
• Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centres
  British Journal of Haematology, 2001